VLA Share Price

Open 1.19 Change Price %
High 1.22 1 Day 0.03 2.54
Low 1.18 1 Week 0.04 3.42
Close 1.21 1 Month 0.11 10.00
Volume 93131 1 Year 0.56 86.15
52 Week High 1.35
52 Week Low 0.62
VLA Important Levels
Resistance 2 1.25
Resistance 1 1.23
Pivot 1.20
Support 1 1.19
Support 2 1.17
ASX Australia Most Active Stocks
TON 0.10 66.67%
TON 0.10 66.67%
TON 0.10 66.67%
GPP 0.03 0.00%
AKK 0.01 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
TEG 0.00 0.00%
TEG 0.00 0.00%
More..
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
SBI 0.02 100.00%
SBI 0.02 100.00%
TON 0.10 66.67%
TON 0.10 66.67%
TON 0.10 66.67%
MMR 0.03 50.00%
MMR 0.03 50.00%
MMR 0.03 50.00%
PMQ 0.03 50.00%
More..
ASX Australia Top Losers Stocks
BPH 0.00 -100.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
NMI 0.01 -50.00%
NMI 0.01 -50.00%
NMI 0.01 -50.00%
GMD 0.02 -33.33%
More..

Viralytics Ltd (ASX: VLA)

VLA Technical Analysis 5
As on 6th Dec 2016 VLA Share Price closed @ 1.21 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.89 & Strong Buy for SHORT-TERM with Stoploss of 1.11 we also expect STOCK to react on Following IMPORTANT LEVELS.
VLA Target for December
1st Target up-side 1.33
2nd Target up-side 1.46
3rd Target up-side 1.59
1st Target down-side 0.95
2nd Target down-side 0.82
3rd Target down-side 0.69
VLA Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.viralytics.com
VLA Address
VLA
66 Hunter Street
Suite 305
Sydney, NSW 2000
Australia
Phone: 61 2 9988 4000
Fax: 61 2 8068 6038
VLA Latest News
Keeping an Eye on Shares of Viralytics Limited (ASX:VLA)   Marion Business Daily   - 06th Dec 16
Inside the Numbers: Looking at This Stock: Viralytics Limited (VLA.AX)   StockTalk Daily   - 06th Dec 16
Viralytics Ltd reveals positive cancer immunotherapy results   Proactive Investors Australia   - 14th Nov 16
VIRALYTICS LTD SPON ADR EACH REPR 3 (VRACY) Given Average Recommendation of ...   DailyQuint   - 22nd Oct 16
Broker names 3 shares under $1 worth a close look   Motley Fool Australia   - 19th May 16
Biotech Investors Should Not Ignore Australia's Opportunities   Equities.com   - 12th May 16
4 small cap shares sliding on the ASX today   Motley Fool Australia   - 21st Apr 16
Viralytics Ltd reports positive results of melanoma cancer fighting combination   Proactive Investors Australia   - 19th Apr 16
Viralytics bags $4M to advance cancer treatment   Proactive Investors Australia   - 25th Jan 16
What's Happening to the Share Price of Viralytics Limited?   Daily Reckoning - Australian Edition   - 10th Jun 15
Interactive Technical Analysis Chart Viralytics Ltd ( VLA ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Viralytics Ltd
VLA Business Profile
Viralytics Limited, a biotechnology company, develops oncolytic virotherapy for the treatment of a range of cancers primarily in Australia. The company primarily develops CAVATAK, a Phase II clinical trial product for the treatment of late stage melanoma; has completed a Phase I single dose-escalation intravenous study for the treatment of melanoma, breast, prostate, and colon cancers; and has completed a multi dose intratumoral trial for the treatment of late stage head and neck cancers. It also develops EVATAK, which is in a preclinical stage for the treatment of gastric and ovarian cancers. The company was formerly known as Psiron Ltd. and changed its name to Viralytics Limited in December 2006. Viralytics Limited is headquartered in Sydney, Australia.